{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:03:34Z","timestamp":1698735814570},"reference-count":9,"publisher":"Japanese Society of Toxicologic Pathology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Toxicol Pathol"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1293\/tox.2022-0110","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T22:10:18Z","timestamp":1671660618000},"page":"145-149","source":"Crossref","is-referenced-by-count":1,"title":["Comparative analysis of neurofilament light chain levels in the serum and          cerebrospinal fluid in rats subjected to partial sciatic nerve ligation"],"prefix":"10.1293","volume":"36","author":[{"given":"Tomoya","family":"Sano","sequence":"first","affiliation":[{"name":"Drug Safety Research and Evaluation, Takeda              Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa              251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Masuda","sequence":"additional","affiliation":[{"name":"Drug Metabolism and Pharmacokinetics Research              Laboratories, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome,              Fujisawa, Kanagawa 251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Yasuno","sequence":"additional","affiliation":[{"name":"Drug Safety Research and Evaluation, Takeda              Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa              251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Drug Safety Research and Evaluation, Takeda              Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa              251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiro","family":"Shinozawa","sequence":"additional","affiliation":[{"name":"Drug Safety Research and Evaluation, Takeda              Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa              251-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"121","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1.  Khalil              M,                Teunissen              CE,                Otto              M,                Piehl              F,                Sormani              MP,                Gattringer              T,                Barro              C,                Kappos              L,                Comabella              M,                Fazekas              F,                Petzold              A,                Blennow              K,                Zetterberg              H, and                Kuhle              J.            Neurofilaments as biomarkers in neurological disorders.            Nat Rev Neurol. 14:            577\u2013589. 2018.","DOI":"10.1038\/s41582-018-0058-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2.  Meregalli              C,                Fumagalli              G,                Alberti              P,                Canta              A,                Carozzi              VA,                Chiorazzi              A,                Monza              L,                Pozzi              E,                Sandelius              \u00c5,                Blennow              K,                Zetterberg              H,                Marmiroli              P, and                Cavaletti              G.            Neurofilament light chain as disease biomarker in a rodent model of            chemotherapy induced peripheral neuropathy. Exp Neurol.            307: 129\u2013132. 2018.","DOI":"10.1016\/j.expneurol.2018.06.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3.  Kim              SH,                Choi              MK,                Park              NY,                Hyun              JW,                Lee              MY,                Kim              HJ,                Jung              SK, and                Cha              Y. Serum            neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of            oxaliplatin-induced peripheral neuropathy. Sci Rep.            10: 7995. 2020.","DOI":"10.1038\/s41598-020-64511-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4.  Meregalli              C,                Fumagalli              G,                Alberti              P,                Canta              A,                Chiorazzi              A,                Monza              L,                Pozzi              E,                Carozzi              VA,                Blennow              K,                Zetterberg              H,                Cavaletti              G, and                Marmiroli              P.            Neurofilament light chain: a specific serum biomarker of axonal damage            severity in rat models of chemotherapy-induced peripheral neurotoxicity.            Arch Toxicol. 94:            2517\u20132522. 2020.","DOI":"10.1007\/s00204-020-02755-w"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5.  Sano              T,                Masuda              Y,                Yasuno              H,                Shinozawa              T,                Watanabe              T, and                Kakehi              M. Blood            neurofilament light chain as a potential biomarker for central and peripheral nervous            toxicity in rats. Toxicol Sci. 185:            10\u201318. 2021.","DOI":"10.1093\/toxsci\/kfab122"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6.  Bolon              B,                Garman              RH,                Pardo              ID,                Jensen              K,                Sills              RC,                Roulois              A,                Radovsky              A,                Bradley              A,                Andrews-Jones              L,                Butt              M, and                Gumprecht              L. STP position            paper: recommended practices for sampling and processing the nervous system (brain,            spinal cord, nerve, and eye) during nonclinical general toxicity          studies. Toxicol Pathol. 41:            1028\u20131048. 2013.","DOI":"10.1177\/0192623312474865"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7.  Fader              KA,                Pardo              ID,                Kovi              RC,                Somps              CJ,                Wang              HH,                Vaidya              VS,                Ramaiah              SK, and                Sirivelu              MP. Circulating            neurofilament light chain as a promising biomarker of AAV-induced dorsal root ganglia            toxicity in nonclinical toxicology species. Mol Ther Methods            Clin Dev. 25: 264\u2013277.            2022.","DOI":"10.1016\/j.omtm.2022.03.017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8.  Trojanowski              JQ,                Walkenstein              N, and                Lee              VM. Expression            of neurofilament subunits in neurons of the central and peripheral nervous system: an            immunohistochemical study with monoclonal antibodies. J            Neurosci. 6: 650\u2013660.            1986.","DOI":"10.1523\/JNEUROSCI.06-03-00650.1986"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9.  Joukal              M,                Klus\u00e1kov\u00e1              I, and                Dubov\u00fd              P. Direct            communication of the spinal subarachnoid space with the rat dorsal root            ganglia. Ann Anat. 205:            9\u201315. 2016.","DOI":"10.1016\/j.aanat.2016.01.004"}],"container-title":["Journal of Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/36\/2\/36_2022-0110\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T03:42:01Z","timestamp":1681530121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/36\/2\/36_2022-0110\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1293\/tox.2022-0110","relation":{},"ISSN":["0914-9198","1881-915X"],"issn-type":[{"value":"0914-9198","type":"print"},{"value":"1881-915X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"2022-0110"}}